Stoneridge Centers for Brain and Addition Treatment
-
Services:
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- 12-step facilitation
- Trauma-related counseling
- Substance use disorder counseling
- Cognitive behavioral therapy
- Brief intervention
- Relapse prevention
- Motivational interviewing
- Vaping permitted in designated area
- TB screening
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- STD testing
- HIV testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- Testing for Hepatitis B (HBV)
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Mental health services
- Case management service
- Social skills development
- Assistance with obtaining social services
- Self-help groups
- Employment counseling or training
- Housing services
- This facility administers/prescribes medication for alcohol use disorder
- Comprehensive mental health assessment
- Screening for mental disorders
- Screening for substance use
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for tobacco use
- Medicaid
- Cash or self-payment
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient day treatment or partial hospitalization
- Intensive outpatient treatment
- Regular outpatient treatment
- Outpatient
- Substance use disorder education
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Individual counseling
- Group counseling
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Buprenorphine maintenance
- Aftercare/continuing care
- Discharge Planning
- Outcome follow-up after discharge
- Naloxone and overdose education
- Smoking permitted in designated area
- Treatment for gambling disorder
- State mental health department
- SAMHSA certification for opioid treatment program (OTP)
- The Joint Commission
- Criminal justice (other than DUI/DWI)/Forensic clients
- Adult women
- Clients who have experienced intimate partner violence, domestic violence
- Adult men
- Veterans
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Members of military families
- Clients who have experienced trauma
- Clients with co-occurring pain and substance use disorders
- Pregnant/postpartum women
- Clients with HIV or AIDS
- Seniors or older adults
- Clients who have experienced sexual abuse
- Clients with co-occurring mental and substance use disorders
- Adults
- Young Adults
- Sliding fee scale (fee is based on income and other factors)
- Male
- Female
- Other contracted prescribing entity
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Clonidine
- Acamprosate (Campral®)
- Nicotine replacement
- Medication for mental disorders
- Buprenorphine (extended-release, injectable)
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Private for-profit organization
Opioid Medications used in Treatment
Treatment Approaches
Facility Vaping Policy
Testing
Type of Care
Ancillary Services
Recovery Support Services
Type of Alcohol Use Disorder Treatment
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Education and Counseling Services
Type of Opioid Treatment
Transitional Services
Facility Smoking Policy
Other Services
License/Certification/Accreditation
Special Programs/Groups Offered
Age Groups Accepted
Payment Assistance Available
Gender Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Pharmacotherapies
Facility Operation (e.g., Private, Public)






